Let’s Be DIRECT: We Have An Access and Affordability Problem to Solve

Schedule a meeting to connect with one of our experts to explore whether a direct-to-patient or direct-to-provider model could be a good fit to your brand’s access and affordability strategy.

---

The pharmaceutical industry is at an inflection point. Rising costs, opaque pricing and fragmented care are straining every part of the healthcare ecosystem. Patients, payers, pharma, providers, and pharmacies are all feeling the pain of misaligned incentives in a system that is harder to navigate than it should be. There is a dire need for new thinking—not for fixing old processes. While direct-to-patient (DTP) may be the latest buzzworthy term, it is not a silver bullet, and we already see the need to go beyond it.  

 That’s why we led the merger of EVERSANA and Waltz Health to bring together two organizations committed to rewiring the system for better access and affordability. Now, as a single combined entity, our company is in a unique position at a very urgent time. We have proprietary patient and payer technology platforms, combined with patient hub, marketing, field deployment, pricing, and channel management services, to reimagine modern market access through a brand-new model. We are calling it: EVERSANA DIRECT or more cleverly DTP2 – bringing together Direct-to-Patient and Direct-to-Payer models to create a truly new, consistent, transparent, and reliable way for therapies to reach patients. 

Download this article to learn more how:

• EVERSANA DIRECT Empowers Payers Through Modernized PBM Functions 
• EVERSANA DIRECT Empowers Pharma Through New Channels 

 In today’s pharma landscape, market access is the problem to solve—and with the combined capabilities of EVERSANA and Waltz Health technology, we can solve it. By combining direct-to-patient access models with direct-to-payer technology, we are reimagining the pharmaceutical access ecosystem to address patient experience, costs, transparency, and care coordination. Payers, pharma, and—most importantly—patients ultimately win. 

Schedule a meeting to connect with one of our experts to explore whether DIRECT could be a good fit to your brand’s access and affordability strategy.